Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
about
Updating the landscape of direct-to-consumer pharmacogenomic testing.Introducing personalized health for the family: the experience of a single hospital system.Pharmacogenomics and big genomic data: from lab to clinic and back again.User considerations in assessing pharmacogenomic tests and their clinical support toolsQualitative user evaluation of a revised pharmacogenetic educational toolkit
P2860
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@en
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@nl
type
label
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@en
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@nl
prefLabel
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@en
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@nl
P2093
P2860
P356
P1476
Pharmacogenomics-Based Point-o ...... antly Alters Drug Prescribing.
@en
P2093
B A Borden
D L Burnet
D O Meltzer
P2860
P304
P356
10.1002/CPT.709
P407
P577
2017-04-11T00:00:00Z